Denmark Vaccine Contract Manufacturing Market Size & Outlook

The vaccine contract manufacturing market in Denmark is expected to reach a projected revenue of US$ 105.2 million by 2030. A compound annual growth rate of 4.6% is expected of Denmark vaccine contract manufacturing market from 2025 to 2030.
Revenue, 2024 (US$M)
$80.5
Forecast, 2030 (US$M)
$105.2
CAGR, 2025 - 2030
4.6%
Report Coverage
Denmark

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Denmark vaccine contract manufacturing market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Denmark vaccine contract manufacturing market highlights

  • The Denmark vaccine contract manufacturing market generated a revenue of USD 80.5 million in 2024 and is expected to reach USD 105.2 million by 2030.
  • The Denmark market is expected to grow at a CAGR of 4.6% from 2025 to 2030.
  • In terms of segment, attenuated vaccine was the largest revenue generating vaccine type in 2024.
  • DNA Vaccines is the most lucrative vaccine type segment registering the fastest growth during the forecast period.


Vaccine contract manufacturing market data book summary

Market revenue in 2024USD 80.5 million
Market revenue in 2030USD 105.2 million
Growth rate4.6% (CAGR from 2025 to 2030)
Largest segmentAttenuated vaccine
Fastest growing segmentDNA Vaccines
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSubunit Vaccines, Attenuated Vaccine, Inactivated Vaccine, Toxoid Vaccines, DNA Vaccines
Key market players worldwideLonza Group Ltd, FUJIFILM Holdings Corp, Merck KGaA, Catalent Inc, Icon PLC, Syngene, Curia, Ajinomoto Co Inc, IDT Biologika


Other key industry trends

  • In terms of revenue, Denmark accounted for 1.7% of the global vaccine contract manufacturing market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany vaccine contract manufacturing market is projected to lead the regional market in terms of revenue in 2030.
  • France is the fastest growing regional market in Europe and is projected to reach USD 336.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Vaccine Contract Manufacturing Market Companies

Name Profile # Employees HQ Website
IDT Biologika View profile 1001-5000 Dessau, Sachsen-Anhalt, Germany, Europe https://idt-biologika.de/
Syngene View profile 1001-5000 Bangalore, Karnataka, India, Asia http://www.syngeneintl.com
Curia View profile 1001-5000 Albany, New York, United States, North America https://curiaglobal.com
Ajinomoto Co Inc View profile 43318 15-1, Kyobashi 1-chome, Chuo-ku, Tokyo, Japan, 104-8315 http://www.ajinomoto.co.jp
Catalent Inc View profile 17219 14 Schoolhouse Road, Somerset, NJ, United States, 08873 https://www.catalent.com
Icon PLC View profile 41150 South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 https://www.iconplc.com
FUJIFILM Holdings Corp View profile 83784 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 http://www.fujifilmholdings.com
Lonza Group Ltd View profile 18000 Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 https://www.lonza.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com

Denmark vaccine contract manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vaccine contract manufacturing market will help companies and investors design strategic landscapes.


Attenuated vaccine was the largest segment with a revenue share of 29.57% in 2024. Horizon Databook has segmented the Denmark vaccine contract manufacturing market based on subunit vaccines, attenuated vaccine, inactivated vaccine, toxoid vaccines, dna vaccines covering the revenue growth of each sub-segment from 2018 to 2030.


Outsourcing in the Denmark pharmaceutical industry has been growing in recent years. This trend is driven by several factors, including the need to reduce costs, increase efficiency, and access specialized expertise & technologies.

Denmark has a strong reputation for high-quality pharmaceuticals, and many companies are attracted to the country's well-developed infrastructure & highly skilled workforce. Some of the key players in the vaccine contract manufacturing market are Catalent, Inc. and Lonza Group.

In addition, local pharmaceutical companies are exhibiting an increase in demand for CMO services, owing to the country's reputation for quality services & availability of specialized services, such as contract research & manufacturing.

Reasons to subscribe to Denmark vaccine contract manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Denmark vaccine contract manufacturing market databook

  • Our clientele includes a mix of vaccine contract manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Denmark vaccine contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Denmark vaccine contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Denmark vaccine contract manufacturing market size, by vaccine type, 2018-2030 (US$M)

Denmark Vaccine Contract Manufacturing Market Outlook Share, 2024 & 2030 (US$M)

Denmark vaccine contract manufacturing market size, by vaccine type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online